e-z cinnamic acid has been researched along with Adenocarcinoma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mabeta, P; Pavić, K; Zorc, B | 1 |
| Huang, Y; Le, H; Liu, X; Xu, L; Zeng, F; Zhou, J | 1 |
| Jayashree, BS; Kumar, N; Nayak, PG; Pai, KS; Prasad, VG; Rao, CM; Reddy, ND; Shoja, MH | 1 |
| Chen, YL; Hsu, CL; Sun, FM; Tsai, CM; Weng, CJ; Yen, GC | 1 |
4 other study(ies) available for e-z cinnamic acid and Adenocarcinoma
| Article | Year |
|---|---|
Insights into the mechanism of antiproliferative effects of primaquine-cinnamic acid conjugates on MCF-7 cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cinnamates; Colorectal Neoplasms; Enzyme-Linked Immunosorbent Assay; Female; HeLa Cells; Humans; MCF-7 Cells; Neoplasm Invasiveness; Primaquine; Uterine Cervical Neoplasms | 2018 |
Anticancer effects of cinnamic acid in lung adenocarcinoma cell line h1299-derived stem-like cells.
Topics: AC133 Antigen; Adenocarcinoma; Animals; Antigens, CD; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cinnamates; Cisplatin; Drug Resistance, Neoplasm; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Lung Neoplasms; Mice, Inbred BALB C; Neoplasm Invasiveness; Neoplastic Stem Cells; Paclitaxel; Peptides; Xenograft Model Antitumor Assays | 2013 |
In vitro and in vivo evaluation of novel cinnamyl sulfonamide hydroxamate derivative against colon adenocarcinoma.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cinnamates; Colon; Colonic Neoplasms; Female; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Models, Molecular; Rats, Wistar; Sulfonamides | 2015 |
Molecular mechanism depressing PMA-induced invasive behaviors in human lung adenocarcinoma cells by cis- and trans-cinnamic acid.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Carcinogens; Cell Line, Tumor; Cinnamates; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Models, Biological; Neoplasm Invasiveness; Neoplasm Proteins; Osmolar Concentration; Stereoisomerism; Tetradecanoylphorbol Acetate; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Urokinase-Type Plasminogen Activator | 2013 |